CDKN1A and pancreatic neoplasm: Taken together, our results strongly suggest that TH301 exerts opposite actions on p21 (remarkable induction) and Survivin (notable reduction) protein expression patterns that occur independently of CRY2 modulation in human pancreatic cancer cell settings.